Search filters

List of works by Ilirjana Bajrami

A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity

scientific article

APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer

scientific article

Abstract 2931: Cancer cells deficient in DNA mismatch repair (MMR) are selectively sensitive to inhibition of the DNA dependent protein kinase (DNA-PK)

scientific article published on 30 September 2014

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

scientific article

Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling

scientific article published on 28 August 2014

Functional viability profiles of breast cancer

scientific article

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells

scientific article

Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity

scientific article

Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN.

scientific article published on May 2013

Identification of miRNA modulators to PARP inhibitor response

scientific article published on 6 April 2013

Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines

scientific article published on 2 March 2016

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

scientific article

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer

article by Roman M Chabanon et al published 1 March 2019 in Journal of Clinical Investigation

Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib

scientific article

Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells

scientific article